£426k
+10%vs Dec 2024Active11578466Private limited companyBexley
SMP PHARMA LIMITED
Significant control: Sweta Patel (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Smp Pharma Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Smp Pharma Limited sell?
Registered activity: Activities of other holding companies n.e.c. (SIC 64209). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
SMP PHARMA LIMITED is an active private limited company (company number 11578466) incorporated on 19 September 2018, registered in Bexley. Its registered activity is activities of other holding companies n.e.c. (SIC 64209). Latest small accounts cover the period ending 31 December 2025, showing net assets of £426k and cash of £17k, with 2 employees on average. Net assets rose 10% on the prior period (£387k).
Peer position · net assets
By net assets it sits in the top quarter of 4,500 comparable companies in Greater London (median £100, upper quartile £90k).
02
Ownership and control
- Mrs Sweta Patel
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Mr Mithul Patel
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 19 September 20188 yrs ago
- Next accounts due
- 30 September 2027in 340 days
- Confirmation statement due
- 3 October 2027in 343 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 64209
- Activities of other holding companies n.e.c.
- SIC 68100
- Buying and selling of own real estate
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£17k
+25%vs Dec 2024Not reported
2
No changevs Dec 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £426k | £17k | £42k | — | — | — | 2 |
| 31 December 2024 | £387k | £14k | £120k | — | — | — | 2 |
Cash per employee£8,610Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £426,423 at 31 December 2025
- Net assets up 10% or more on the prior period+10.3% vs prior period
- Incorporated five or more years agoIncorporated 19 September 2018
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 343 days
- Next accounts duein 340 days
- Accounts period endNet assets £426k · small accounts
- Accounts period endNet assets £387k · small accounts
- Incorporated
08
Similar companies in Greater London
- ANASHIM LIMITEDHarrow · inc. Sept 2018
- O'HARA BROS. SURFACING HOLDINGS LIMITEDPinner · inc. Sept 2018
- LEITRIM PROPERTIES HOLDINGS LIMITEDPinner · inc. Sept 2018
- ONYX FINANCE LTD.South Ockendon · inc. Sept 2018
- THREE SIXTY INVESTMENTS NO1 LIMITEDUxbridge · inc. Sept 2018
- WANDERING DODO LIMITEDEdgware · inc. Sept 2018
All companies incorporated on 19 September 2018 · in Sept 2018.
09
Reminders for SMP PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.